Weston strategy firm mulls sell-off option
This article was originally published in Clinica
Executive Summary
Weston Medical, which last week announced staff layoffs to preserve cash following news that its flagship needle-free injection technology will require a redesign on three fronts prior to launch (see Clinica No 1026, 13), has appointed London-based Altium Capital to review the strategic options before the company. The review will include an assessment of funding, merger or sell-off options.